Putney Makes Deloitte’s Technology Fast 500
Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, ranked number 290 on Deloitte’s Technology Fast 500, a ranking of the 500 fastest growing technology, life sciences, telecommunications and media companies in North America.
The company qualified for the recognition as a biotech/pharma company using its proprietary intellectual property in developing FDA approved veterinary generics to drive revenue growth of 304 percent.
“Putney has invested millions of dollars in R&D to develop FDA approved generics of expensive branded veterinary drugs,” Jean Hoffman, president and CEO, said. “We are the only companion animal health company that is focused entirely on developing and commercializing veterinary generics, to help make pet healthcare more affordable.”